Surrogate gene therapy for muscular dystrophy
An engineered truncated gene derived from the dystrophin-related protein (utrophin), prevents pathology without an immune response in an animal model of Duchenne muscular dystrophy (DMD) gene therapy.
主要な著者: | Davies, KE, Chamberlain, JS |
---|---|
フォーマット: | Journal article |
言語: | English |
出版事項: |
Springer Nature
2019
|
類似資料
-
Therapeutic approaches to muscular dystrophy.
著者:: Goyenvalle, A, 等
出版事項: (2011) -
The Pathogenesis and Therapy of Muscular Dystrophies
著者:: Guiraud, S, 等
出版事項: (2015) -
Progress in therapy for Duchenne muscular dystrophy.
著者:: Fairclough, R, 等
出版事項: (2011) -
Progress in therapy for Duchenne muscular dystrophy
著者:: Fairclough, R, 等
出版事項: (2011) -
Utrophin in the therapy of Duchenne Muscular Dystrophy
著者:: Potter, A, 等
出版事項: (2006)